UBS AM
SGHT icon

UBS AM’s Sight Sciences SGHT Stock Holding History

UBS AM’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65K Hold
488
– – ﹤0.01% 3499
2026
Q1 		$1.84K Buy
+488
New +$2.63K ﹤0.01% 3611
2021
Q4 		– Sell
-82,589
Closed -$1.87M – 2894
2021
Q3 		$1.87M Buy
+82,589
New +$2.71M ﹤0.01% 1869

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS AM's SGHT Position: Q2 2026 in Review

UBS AM held its Sight Sciences (SGHT) position steady in Q2 2026 at 488 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

UBS AM first reported a position in SGHT in Q3 2021 and has held it in 3 quarters since. The position peaked at $1.87M in Q3 2021. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • UBS AM held 488 shares of Sight Sciences worth $2.65K as of Q2 2026.
  • UBS AM left its Sight Sciences share count unchanged in Q2 2026.
  • Sight Sciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3499 holding.
  • UBS AM first reported a position in Sight Sciences in Q3 2021 and has held it in 3 quarters since.
  • UBS AM's Sight Sciences position peaked at $1.87M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.